AU Patent

AU2004283047B2 — Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker

Assigned to Abbott Laboratories GmbH · Expires 2009-09-17 · 17y expired

What this patent protects

Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hyp…

USPTO Abstract

Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004283047B2
Jurisdiction
AU
Classification
—
Expires
2009-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.